Skip to main
IQV
IQV logo

IQVIA Hlds (IQV) Stock Forecast & Price Target

IQVIA Hlds (IQV) Analyst Ratings

Based on 33 analyst ratings
Buy
Strong Buy 42%
Buy 36%
Hold 21%
Sell 0%
Strong Sell 0%

Bulls say

IQVIA Holdings showcases a positive outlook due to a robust 5% increase in request for proposals (RFP) flow across all market segments, particularly strong within the early stage operations, suggesting a favorable demand environment. The company’s ability to capitalize on this demand is further underscored by a 5.5% growth in backlog, indicating a solid pipeline for future revenue growth as it stabilizes. Additionally, IQVIA's strategic plan to deploy $2 billion in capital for mergers and acquisitions and share repurchases in 2025, combined with anticipated revenue growth of 4-7% in its Research & Development Services segment, reinforces the optimistic outlook for the company going forward.

Bears say

IQVIA Holdings Inc. faces a challenging financial outlook due to prolonged COVID-related impacts, rising interest expenses, and a deteriorating funding environment in the biopharma sector, which has adversely affected investor sentiment and earnings per share (EPS) growth since the first quarter of 2022. The company's backlog has remained flat, compounded by foreign exchange headwinds leading to a significant downward revision of previously reported backlog figures, indicating potential difficulties in securing new contracts. Furthermore, a competitive pricing landscape and declining gross margins—driven by revenue mix and increased costs from delayed trials—are likely to hinder growth prospects and contribute to ongoing earnings pressure amidst an uncertain macroeconomic environment.

IQVIA Hlds (IQV) has been analyzed by 33 analysts, with a consensus rating of Buy. 42% of analysts recommend a Strong Buy, 36% recommend Buy, 21% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of IQVIA Hlds and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About IQVIA Hlds (IQV) Forecast

Analysts have given IQVIA Hlds (IQV) a Buy based on their latest research and market trends.

According to 33 analysts, IQVIA Hlds (IQV) has a Buy consensus rating as of Jul 12, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $219.76, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $219.76, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

IQVIA Hlds (IQV)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.